维普期刊资源整合服务平台（V6.5）

46篇 您的检索式：作者名="Forst B"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Exenatide once weekly versus lira- glutide once daily in patients with type 2 diabetes (DURATION-6) : a randomised, open-label study显示文摘	Buse J B Nauck M Forst T	2013	Lancet2013，381，9861：	1
2	The oral DPP-4 inhibitor lina- gliptin significantly lowers HbAlc after 4 weeks of treatment in pa- tients with type 2 diabetes mellitus 显示文摘	Forst T Uhlig-Lasker B Ring A	2011	Diabetes Obes Metab2011，13，6：	1
3	Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high Cardiovascular risk 显示文摘	Forst T Wilhelm B Pftitzner A	2008	Diab Vasc Dis Res2008，5，4：	1
4	Linagliptin (BI 1356),a potent and selective DPP-4 inhibitor,is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes显示文摘	FORST T UHLIG-LASKE B RING A	2010	Diabet Med2010，27，12：	1
5	Ageochem/eal classification for granitierocks 显示文摘	Forst B R Barnes C G Collins W J Arculus R J Ellis D J Frost C D	2001	Journal of Petrology2001，42，：	1
6	Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice显示文摘	Forst B Hansen MT Klinqelhofer J	2010	PLos One2010，5，10：	1
7	Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk显示文摘	Forst T Wilhelm B Pfutxner A		0，，04：	1
8	Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk显示文摘	Forst T Wilhelm B Pfutzmer A		0，，04：	1
9	Bone mineral density and bone metabolism in diabetes mellitus显示文摘	Piepkorn B Kann P Forst T	1997	Horm Metab Res1997，29，：	1
10	Conformation and dynamics of heparin and heparan sulfate显示文摘	Mulloy B Forste MJ	2000	Glycobiology2000，10，11：	1
11	The oral DPP-4 inhibitor linagliptin significantly lowers HbAlc after 4 weeks of treatment in patients with type 2 diabetes mellitus显示文摘	FORST T UHLIG-LASKE B RING A	2011	Diabetes Obes Metab2011，13，6：	1
12	Linagliptin(BI1356),a potent and selective DPP-4 inhibitor,is safe and efficacious in combination with metformin in patients with inadequately controlled type 2 diabetes显示文摘	FORST T UHLIG-LASKE B RING A	2010	Diabet Med2010，27，12：	1
13	The oral DPP-4 inhibitor linagliptin significantly lowers HbA~c after g weeks of treatment in patients with type 2 diabetes mellitus显示文摘	FORST T UHLIG-LASKE B RING A et ol	2011	Diabetes Obes Metab2011，13，6：	1
14	Local and global function of the right ventricle in a canine model of pulmonary microembolism and oleic acid edema: influence of ventilation with PEEP显示文摘	Zwissler B Forst H Messmer K	1990	Anesthesiology1990，73，5：	1
15	Evaluation of CGMS during rapid blood glucose changes in patients with Type 1 Diabetes显示文摘	Wilhelm B Forst S Weber MM	2006	Diabetes Technol Ther2006，8，2：	1
16	Linagliptin (BI 1356), a potent and selective DPP- 4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled type 2 diabetes显示文摘	FORST T UHLIG-LASKE B RING A	2010	Diabet Med2010，27，12：	1
17	Role of C-Peptide in the regulation of microvescular blood flow显示文摘	Forst T Kunt T Wilhelm B	2008	Exp Diabetes Res2008，2008，17：	1
18	Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes 显示文摘	Forst T Uhlig-Laske B Ring A	2010	Diabet Med2010，27，12：	1
19	Local and global function of the right ventricle in a canine model of pulmonary microembolism and o- leie acid edema: influence of ventilation with PEEP显示文摘	Zwissler B Forst H Messmer K	1990	Anesthesi- ology1990，73，5：	1
20	Discrimination of three parallel pathways of lactate transport in the human erythrocyte membrane by inhibitors and kinetic properties显示文摘	Deuticke B Beyer E Forst B	1982	Biochim Biophys Acta1982，684，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示